Celmatix Therapeutics is a preclinical-stage women’s health biotech focused on advancing groundbreaking therapeutics for women’s health. With its growing pipeline of innovative drug programs including an AMHR2 agonist program focused on ovarian aging, an oral FSH for infertility, and a JNK inhibitor program for endometriosis, Celmatix Therapeutics is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in women’s health. For more information, visit the company’s website at www.celmatix.com.
Looking for a particular Celmatix employee's phone or email?
Celmatix Questions
The Celmatix annual revenue was $21.8 million in 2026.
Caterina Clementi is the Vice President of Biological Sciences of Celmatix.
13 people are employed at Celmatix.
Celmatix is based in New York, New York.
The NAICS codes for Celmatix are [5417, 541, 541714, 54, 54171].
The SIC codes for Celmatix are [87, 873].
Top Celmatix Employees
-
Caterina Clementi
Vice President of Biological Sciences at Celmatix
New York, NY, US23 -
45+
-
Karen Cohn
Scientific Advisor at Celmatix
New York, NY, US22 -
Joe B.
Vice President Finance at Celmatix
New York, NY, US
Related Companies
